The Added Value of Baseline Circulating Tumor DNA Profiling in Patients with Molecularly Hyperselected, Left-sided Metastatic Colorectal Cancer.
Francesco PantanoSalvatore CoralloAdele BusicoSara LonardiFrancesca CortiCarlotta AntoniottiLetizia ProcaccioMatteo ClavarezzaValeria SmiroldoGianluca TomaselloRoberto MurialdoAndrea Sartore-BianchiPatrizia RaccaFilippo PaganiGiovanni RandonAntonia MartinettiElisa SottotettiFederica PalermoFederica PerroneElena TamboriniMichele PrisciandaroAlessandra RaimondiMaria Di BartolomeoFederica MoranoFilippo PietrantonioPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Baseline ctDNA profiling may add value to tumor tissue testing to refine the molecular hyperselection of patients with mCRC for upfront anti-EGFR-based strategies.